Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atr... (illion in sponsored research agreements....)

HOME >> BIOLOGY >> TECHNOLOGY

Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)

Date:9/15/2008

illion in sponsored research agreements. In addition, the Foundation is committed to raising awareness and generating support for increased research efforts in SMA among the leaders of industry and government.

For more than 16 years Assay Designs has supplied the worldwide biomedical research community with immunoanalytical assay solutions for the precise quantification of biomarkers in a variety of sample matrices and species. Since 2005 ADI also provides the full spectrum of Stressgen(R) immunological reagents such as antibodies and proteins, to aid drug discovery and basic research. Assay Designs offers customers one-stop-shop custom development services from antibody and recombinant protein production to the development, validation, and manufacturing of biomarker assays, providing a seamless transition and scale up from pre-clinical to clinical applications.

The collaboration with SMAF is in alignment with Assay Designs' mission to provide researchers with high quality reagents and assays to expedite their efforts in developing new cures and improving the quality of life for patients.

About Assay Designs, Inc.

Based in Ann Arbor, MI, Assay Designs develops and manufactures immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and extracts used for life sciences research. The company markets these products under the "Assay Designs" and "Stressgen" brand names. Researchers use the company's products to detect and quantify molecules that are important in inflammation, cell signaling, and cellular stress.

0

GOOD

Page: 1 2
Related biology technology :

1. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay
2. Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC
3. FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
4. Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
5. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
6. Sensitivity Enhancements to Monograms Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy
7. Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting
8. Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
9. Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay
10. Assay Designs(TM) Announces Collaboration with Medical University of South Carolina (MUSC)
11. HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics

Post Your Comments:

Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atr...(illion in sponsored research agreements....)